OBJECTIVES: Although targeting the effect site concentration may offer advantages over the traditional forms of administering intravenous anesthetics, it is not applicable for sufentanil in children because its plasma effect site equilibration rate constant (ke0) is not known yet. We estimated ke0 of sufentanil in children using the time to peak effect (t peak) method. MATERIALS AND METHODS: Under general anesthesia, sufentanil t peak was measured after administration of a submaximal bolus dose by means of the decrease in heart rate, blood pressure and calculated approximate entropy (ApEn) of electroencephalogram in 105 children (age range: 3-11 years). ke0 was estimated using t peak and known sufentanil pharmacokinetic parameters in normal children. RESULTS: The mean t peaks were measured as 44 ± 22 s and 227 ± 91 s by heart rate and by mean blood pressure respectively. The estimated ke0 were 5.16/min and 0.49/min by heart rate and blood pressure respectively. t peak could not be measured using the ApEn, thus ke0 could not be calculated by ApEn in children. CONCLUSIONS: Shorter measured sufentanil t peak by heart rate compared to blood pressure indicate that the heart rate decrease faster than decreasing of blood pressure. Moreover, the calculated sufentanil ke0 in children depends on the pharmacodynamics parameters.
OBJECTIVES: Although targeting the effect site concentration may offer advantages over the traditional forms of administering intravenous anesthetics, it is not applicable for sufentanil in children because its plasma effect site equilibration rate constant (ke0) is not known yet. We estimated ke0 of sufentanil in children using the time to peak effect (t peak) method. MATERIALS AND METHODS: Under general anesthesia, sufentanil t peak was measured after administration of a submaximal bolus dose by means of the decrease in heart rate, blood pressure and calculated approximate entropy (ApEn) of electroencephalogram in 105 children (age range: 3-11 years). ke0 was estimated using t peak and known sufentanil pharmacokinetic parameters in normal children. RESULTS: The mean t peaks were measured as 44 ± 22 s and 227 ± 91 s by heart rate and by mean blood pressure respectively. The estimated ke0 were 5.16/min and 0.49/min by heart rate and blood pressure respectively. t peak could not be measured using the ApEn, thus ke0 could not be calculated by ApEn in children. CONCLUSIONS: Shorter measured sufentanil t peak by heart rate compared to blood pressure indicate that the heart rate decrease faster than decreasing of blood pressure. Moreover, the calculated sufentanil ke0 in children depends on the pharmacodynamics parameters.
Entities:
Keywords:
Children; plasma effect site equilibration rate constant; sufentanil
Authors: Jun Li; Zhi-Lian Huang; Xu-Tong Zhang; Ke Luo; Zhan-Qin Zhang; Yi Mao; Xiao-Biao Zhuang; Qing-Quan Lian; Hong Cao Journal: Chin Med J (Engl) Date: 2011-11 Impact factor: 2.628
Authors: Nariné Baririan; Luc Van Obbergh; Jean-Pierre Desager; Roger K Verbeeck; Pierre Wallemacq; Peter Starkel; Yves Horsmans Journal: Clin Pharmacokinet Date: 2007 Impact factor: 6.447
Authors: Aurélie Bourgoin; Jacques Albanèse; Marc Léone; Emmanuelle Sampol-Manos; Xavier Viviand; Claude Martin Journal: Crit Care Med Date: 2005-05 Impact factor: 7.598
Authors: Barbara Schultz; Christian Otto; Arthur Schultz; Wilhelm Alexander Osthaus; Terence Krauss; Thorben Dieck; Björn Sander; Niels Rahe-Meyer; Konstantinos Raymondos Journal: PLoS One Date: 2012-07-19 Impact factor: 3.240